DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY
|
|
|
- Hilda Whitehead
- 5 years ago
- Views:
Transcription
1 Date: 10 th April 2018 DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY Request: 1. Utilization Data of Overseas Beam Therapy and Brachytherapy 2. Diagnoses Data of Overseas Claims for Beam Therapy and Brachytherapy Disclaimer: Data provided in this response is provided by the Bermuda Health Council and must be cited and authorized prior to publication or use. Bermuda Health Council does not make any guarantees or provide third party validation for the data sources. Data requests are received from a variety of stakeholders and are used for multiple applications. The data requests presented below are by topic, with specifics such as diagnoses codes and procedures codes often coming from the requestor. As a result, the same topic or condition may show different claims data, due to variability in coding selection. Additionally, as information is received, changes in data capture may occur, which may be corroborated by the dates of the request. Due to the nature of procedure coding, many codes are not mutually exclusive to a specific application or specialty, which means values for office visits, for example, may appear in multiple specialty analytics. Additional information is available, with regard to claim type and diagnosis to discern further follow up, as needed. Finally, analytics for common coding in any field are strictly based on identically matching values. It is possible other, frequent codes exist, but may not be captured if entered in multiple varied formats. The data used to generate this response includes claims data and expenditure from 1 April 2013 to 31 March For any clarification or follow up requests, please healthcouncil@bhec.bm. To submit a data request, please complete an online Data Request Form. Methodology & Data Analysis is presented by procedure code as defined by the ASTRO list of radiation treatment delivery methods 1. (Note: Claims counts do not represent individual patients.) Category Brachytherapy Conventional External Beam Radiation Treatment Delivery Procedures , ,77778,0394T- 0395T, Claims Count Claims Count Claims Count , G6003-G Claims Count 1 ASTRO is an overseas healthcare provider that defines CPT codes for use, here:
2 Intensity Modulated Radiation Therapy Intraoperative Radiation Therapy (IORT) Neutron beam treatment delivery , G6015-G Proton beam treatment delivery SRS treatment delivery SBRT treatment delivery Table 2 represents the diagnosis codes from overseas claims for radiotherapy procedures. (Note: Diagnosis codes listed are primary diagnosis codes for each claim. Each claim may have up to five associated diagnosis codes.) Brachytherapy Conventional External Beam Radiation Treatment Delivery 2017 Diagnoses Keloid Scar C53.8 Malignant neoplasm of overlapping sites of cervix uteri C54.1 Malignant neoplasm of endometrium C61.0 Malignant neoplasm of prostate Z17.0 Estrogen receptor positive status Z51.0 Encounter for antineoplastic radiation Malignant neoplasm of larynx Malignant neoplasm of upper lobe, unspecified bronchus or lung Other and unspecified malignant neoplasm of skin of lip Other and unspecified malignant neoplasm of skin of other and unspecified parts of face Malignant neoplasm of nipple and areola of female breast Malignant neoplasm of central portion of female breast Malignant neoplasm of lower-outer quadrant of female breast Malignant neoplasm of other specified sites of female breast Malignant neoplasm of endocervix Secondary and unspecified malignant neoplasm of axilla and upper limb nodes Secondary malignant neoplasm of bone and bone marrow Secondary malignant neoplasm of breast Other benign neoplasm of skin, unspecified Contact dermatitis and other eczema, unspecified cause General symptoms C Malignant neoplasm of central portion of left female breast C Malignant neoplasm of upper-inner quadrant of right female breast C Malignant neoplasm of upper-outer quadrant of right female breast C Malignant neoplasm of upper-outer quadrant of left female breast C50.91 Malignant neoplasm of breast of unspecified site, female C Malignant neoplasm of unspecified site of right female breast C Malignant neoplasm of unspecified site of left female breast 2
3 Intensity Modulated Radiation Therapy 2017 Diagnoses C53.8 Malignant neoplasm of overlapping sites of cervix uteri C67.8 Malignant neoplasm of overlapping sites of bladder C79.51 Secondary malignant neoplasm of bone C90.30 Solitary plasmacytoma not having achieved remission D05.11 Intraductal carcinoma in situ of right breast V42 Organ or tissue replaced by transplant V86.0 Estrogen receptor positive status Z17.0 Estrogen receptor positive status Z51.0 Encounter for antineoplastic radiation Malignant neoplasm of upper lobe, bronchus or lung Malignant neoplasm of connective and other soft tissue of lower limb, including hip Malignant neoplasm of endocervix Malignant neoplasm of cervix uteri, unspecified site Malignant neoplasm of vagina C01 Malignant neoplasm of base of tongue C09.9 Malignant neoplasm of tonsil C09.8 Malignant neoplasm of overlapping sites of tonsil C21.1 Malignant neoplasm of anal canal C34.12 Malignant neoplasm of upper lobe, left bronchus or lung C Malignant neoplasm of upper-outer quadrant right female breast C Malignant neoplasm of overlapping sites of right female breast C61.0 Malignant neoplasm of prostate C73 Malignant neoplasm of thyroid gland E86.0 Dehydration K12.3 Oral mucositis (ulcerative) R13.1 Dysphagia R13.12 Dysphagia, oropharyngeal phase R63.4 Abnormal weight loss V70.0 Routine medical exam Z51.0 Encounter for antineoplastic radiation Z51.11 Encounter for antineoplastic chemotherapy Z71.3 Dietary counseling and surveillance Z Personal history of nicotine dependence Intraoperative Radiation Therapy (IORT) Neutron beam treatment delivery - - Proton beam treatment delivery SRS treatment delivery SBRT treatment delivery Malignant neoplasm of rectum Malignant neoplasm of retroperitoneum and peritoneum Malignant neoplasm of lower lobe, bronchus or lung 3
4 2017 Diagnoses C79.31 Secondary malignant neoplasm of brain Z51.0 Encounter for antineoplastic radiation therapy Brachytherapy 2016 Diagnoses Malignant neoplasm of other specified sites of cervix Malignant neoplasm of cervix uteri, unspecified site D05.11 Intraductal carcinoma in situ of right breast Z51.0 Encounter for antineoplastic radiation Conventional External Beam Radiation Treatment Delivery Malignant neoplasm of rectum rectosigmoid junction and anus Malignant neoplasm of rectum Malignant neoplasm of main bronchus Malignant neoplasm of upper lobe, unspecified bronchus or lung Malignant neoplasm of central portion of female breast Malignant neoplasm of upper-inner quadrant of female breast Malignant neoplasm of lower-inner quadrant of female breast Malignant neoplasm of other specified sites of female breast Malignant neoplasm of other specified sites of cervix Malignant neoplasm of cervix uteri, unspecified site Malignant neoplasm of vagina Malignant neoplasm of lateral wall of urinary bladder Secondary malignant neoplasm of bone and bone marrow Marginal zone lymphoma Other malignant lymphomas Other benign neoplasm of skin, unspecified Acute venous embolism and thrombosis of deep vessels of lower extremity Down's syndrome General symptoms Nonspecific abnormal electrocardiogram Other complications due to genitourinary device, implant, and graft C Malignant neoplasm of upper-outer quadrant of left female breast C Malignant neoplasm of unspecified site of right female breast C Malignant neoplasm of unspecified site of left female breast C Malignant neoplasm of unspecified site of unspecified female breast C50.31 Malignant neoplasm of lower-inner quadrant of female breast C78.01 Secondary malignant neoplasm of lung C79.51 Secondary malignant neoplasm of bone 4
5 Intensity Modulated Radiation Therapy Intensity Modulated Radiation Therapy 2016 Diagnoses D05.11 Intraductal carcinoma in situ of right breast E918 * Was not entered with decimal and converts to Caught accidentally in or between objects V50.8 Other elective surgery for purposes other than remedying health states Malignant neoplasm of parotid gland Malignant neoplasm of tonsil Malignant neoplasm of glottis Malignant neoplasm of larynx, unspecified Malignant neoplasm of main bronchus Malignant neoplasm of bronchus and lung, unspecified Malignant neoplasm of connective and other soft tissue of head, face, and neck Squamous cell carcinoma of scalp and skin of neck Malignant neoplasm of cervix uteri, unspecified site Malignant neoplasm of retina Malignant neoplasm of frontal lobe Malignant neoplasm of brain, unspecified Malignant neoplasm of head, face, and neck Secondary and unspecified malignant neoplasm of lymph nodes of head, face, and neck Unspecified disease of salivary glands Other specified disorders of male genital organs Alteration of consciousness C20 Malignant neoplasm of rectum C21.0 Malignant neoplasm of anus, unspecified C21.1 Malignant neoplasm of anal canal C49.0 Malignant neoplasm of connective and soft tissue, unspecified C61.0 Malignant neoplasm of prostate C71.3 Malignant neoplasm of parietal lobe C71.9 Malignant neoplasm of brain, unspecified V58.11 Encounter for antineoplastic chemotherapy Z51.0 Encounter for antineoplastic radiation therapy Intraoperative Radiation Therapy (IORT) Neutron beam treatment delivery - - Proton beam treatment delivery SRS treatment delivery SBRT treatment delivery Malignant neoplasm of colon, unspecified site Malignant neoplasm of body of pancreas Other and unspecified malignant neoplasm of skin of other and unspecified parts of face 5
6 2016 Diagnoses Brachytherapy 2015 Diagnoses Intraductal carcinoma in situ of right breast Scabies Conventional External Beam Radiation Treatment Delivery Intensity Modulated Radiation Therapy Malignant neoplasm of rectosigmoid junction Malignant neoplasm of rectum Malignant neoplasm of glottis Malignant neoplasm of upper lobe, unspecified bronchus or lung Malignant neoplasm of bronchus and lung, unspecified Malignant neoplasm of connective and other soft tissue of lower limb, including hip Malignant neoplasm of nipple and areola of female breast Malignant neoplasm of central portion of female breast Malignant neoplasm of upper-inner quadrant of female breast Malignant neoplasm of lower-inner quadrant of female breast Malignant neoplasm of lower-outer quadrant of female breast Malignant neoplasm of other specified sites of female breast Hereditary hemorrhagic telangiectasia Malignant neoplasm of uterus, part unspecified Malignant neoplasm of other specified sites of cervix Malignant neoplasm of vulva, unspecified site Malignant neoplasm of head, face, and neck Secondary malignant neoplasm of bone and bone marrow Secondary malignant neoplasm of breast Modular lymphoma, lymph nodes of head, face, and neck Mycosis fungoides Lymphoid leukemia acute Swelling of limb V15.3 Personal history of irradiation, presenting hazards to health V58.81 Fitting and adjustment of vascular catheter Malignant neoplasm of corpus uteri, except isthmus Malignant neoplasm of vulva, unspecified site 6
7 2015 Diagnoses V49.9 Unspecified problems with limbs and other problems Intraoperative Radiation Therapy (IORT) - - Neutron beam treatment delivery - - Proton beam treatment delivery SRS treatment delivery Malignant neoplasm of upper lobe, bronchus or lung Malignant neoplasm of cerebral meninges SBRT treatment delivery Benign neoplasm of cerebral meninges 2014 Diagnoses Brachytherapy Conventional External Beam Radiation Treatment Delivery Malignant neoplasm of pharynx, unspecified Malignant neoplasm of esophagus Malignant neoplasm of rectum Malignant neoplasm of accessory sinus, unspecified Malignant neoplasm of main bronchus Malignant neoplasm of upper lobe, bronchus or lung Malignant neoplasm of other parts of bronchus or lung Malignant neoplasm of bronchus and lung, unspecified Malignant neoplasm of pelvic bones, sacrum, and coccyx Malignant neoplasm of connective and other soft tissue Malignant melanoma of skin of other and unspecified parts of face Melanoma of skin, site unspecified Other and unspecified malignant neoplasm of skin of other and unspecified parts of face Squamous cell carcinoma of skin of upper limb, including shoulder Malignant neoplasm of central portion of female breast Malignant neoplasm of upper-inner quadrant of female breast Malignant neoplasm of lower-outer quadrant of female breast Malignant neoplasm of other specified sites of female breast Malignant neoplasm of uterus, part unspecified Malignant neoplasm of cervix uteri Malignant neoplasm of exocervix Malignant neoplasm of other specified sites of cervix Malignant neoplasm of other and unspecified female genital organs Malignant neoplasm of thyroid gland Secondary and unspecified malignant neoplasm of lymph nodes Secondary malignant neoplasm of bone and bone marrow 7
8 2014 Diagnoses Other malignant lymphomas Other malignant lymphomas, lymph nodes of inguinal region and lower limb Multiple myeloma and immunoproliferative neoplasms Multiple myeloma, in relapse and genitourinary system Other lymphedema Other specified disorders of rectum and anus Keloid scar Diarrhea Abdominal pain, generalized Conventional External Beam, cont d V10.4 Personal history of malignant neoplasm of other female genital organs 4 V10.8 Personal history of malignant neoplasm of thyroid 7 V72.8 Pre-operative examination, unspecified 4 Intensity Modulated Radiation Therapy - - Intraoperative Radiation Therapy (IORT) - - Neutron beam treatment delivery - - Proton beam treatment delivery - - SRS treatment delivery Secondary malignant neoplasm of bone and bone marrow SBRT treatment delivery Malignant neoplasm of upper lobe, bronchus or lung Additional Information: Clarification of the above data can be made via . Additional data requests can be made using the Data Request Form, available at 8
Cancer Association of South Africa (CANSA)
Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)
MALIGNANT NEOPLASMS OF THE BREAST MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS
MALIGNANT NEOPLASMS OF THE (INC. PAGET S DISEASE) 0 - Nipple and areola 1 - Central portion 2 - Upper-inner quadrant 3 - Lower-inner quadrant 4 - Upper-outer quadrant 5 - Lower-outer quadrant 6 - Axillary
S2 File. Clinical Classifications Software (CCS). The CCS is a
S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous
WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded
82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung
82330 CALCIUM; IONIZED ICD-10 Codes that Support Medical Necessity ICD-10 Code Description A15.0 Tuberculosis of lung A15.4 Tuberculosis of intrathoracic lymph nodes A15.5 Tuberculosis of larynx, trachea
WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not
155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary
ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant
Cancer in Estonia 2014
Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National
CEA (CARCINOEMBRYONIC ANTIGEN)
(CARCINOEMBRYONIC ANTIGEN) 428 C15.3 Malignant neoplasm of upper third of esophagus C15.4 Malignant neoplasm of middle third of esophagus C15.5 Malignant neoplasm of lower third of esophagus C15.8 Malignant
Model Policy. Coverage of Proton Therapy
Model Policy Coverage of Proton Therapy Last Revised - February 2019 INTRODUCTION Proton therapy is a technologically advanced method to deliver curative radiation doses to cancerous tumors. The unique
*
Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The
BCCCP Approved ICD-9 Code List Fiscal Year 2010
BCCCP Approved ICD-9 List Fiscal Year 2010 Diagnosis Description 174.0 Malignant neoplasm of female breast; Nipple and areola 174.1 Malignant neoplasm of female breast; Central portion 174.2 Malignant
CODING PRIMARY SITE. Nadya Dimitrova
CODING PRIMARY SITE Nadya Dimitrova OUTLINE What is coding and why do we need it? ICD-10 and ICD-O ICD-O-3 Topography coding rules ICD-O-3 online WHAT IS CODING AND WHY DO WE NEED IT? Coding: to assign
ANNUAL CANCER REGISTRY REPORT-2005
ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males
Colony Stimulating Factors: Neupogen (filgrastim), Neulasta (pegfilgrastim), Leukine (sargramostim), Granix (tbo-filgrastim)
Neupogen (filgrastim), Neulasta (sargramostim), Granix (tbo-filgrastim) Date of Origin: 10/17/2008 Dates Reviewed: 6/17/2009, 12/22/2009, 06/15/2010/ 7/20/2010, 09/2010, 12/2010, 03/2011, 06/2011, 09/2011,
Intensity Modulated Radiation Therapy (IMRT)
Intensity Modulated Radiation Therapy (IMRT) [For the list of services and procedures that need preauthorization, please refer to www.mcs.com.pr go to Comunicados a Proveedores, and click Cartas Circulares.]
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional
From A to Z-Codes Matter
From A to Z-Codes Matter Susan Wallace, MEd, RHIA, CCS, CDIP, CCDS, FAHIMA While ALL ICD-10-CM codes are important, the Z-codes in ICD-10-CM are frequently considered step-children, supplemental codes
REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after
REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after The following lists are intended to assist you, as the reporter, in identifying the reportable neoplasms for your facility. Any reportable
Nov FromAtoZCodesMatter
Nov 2017 FromAtoZCodesMatter From A to Z-Codes Matter Susan Wallace, MEd, RHIA, CCS, CDIP, CCDS, FAHIMA The implementation of ICD-10 brought tens of thousands of new codes. Ranging from A to Z, they portray
Cancer Program Report 2014
Cancer Program Report 2014 Queen of the Valley Hospital St Joseph Health Queen of the Valley Hospital - 2014 Site Table Site Total Class Sex Group Cases Analytic NonAn M F 0 I II ALL SITES 661 494 167
How ICD-10 Affects Radiation Oncology. Presented by, Lashelle Bolton CPC, COC, CPC-I, CPMA
How ICD-10 Affects Radiation Oncology Presented by, Lashelle Bolton CPC, COC, CPC-I, CPMA ICD-10 ICD-10-CM has added new challenges to the radiation oncology specialty. Approximately 220 ICD-9-CM codes
CLINICAL MEDICATION POLICY
Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICATION POLICY Granulocyte Colony Stimulating Factors (G-CSFs) MP-016-MD-DE Medical Management; Clinical Pharmacy Provider Notice Date:
2017 ICD-10-CM Casefinding List (Abbreviated listing from SEER website) COMPREHENSIVE ICD-10-CM Casefinding Code List for Reportable Tumors
2017 ICD-10-CM Casefinding List (Abbreviated listing from SEER website) COMPREHENSIVE ICD-10-CM Casefinding Code List for Reportable Tumors ICD-10 Code Explanation of Code Malignant neoplasms (excluding
2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill
Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients
APPENDIX ONE: ICD CODES
APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding
BRAF Mutation Analysis
Last Review Date: October 13, 2017 Number: MG.MM.LA.38aC Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way
ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING Central Valley Public Health: Women's Way ICD-9-CM (Top 35) ICD-10-CM ICD-10-CM Description COMMENTS V10.3: Personal history of malignant neoplasm of Z85.3
Neoplasms/Lymphoma/Leukemia
Neoplasms/Lymphoma/Leukemia Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and
Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.
Annual Report Cape Cod Hospital and Falmouth Hospital Regional Cancer Network 2013 Expert physicians. Quality hospitals. Superior care. Cape Cod Hospital s Davenport- Mugar Hematology/Oncology Center and
California Cancer Registry Production Automation and Quality Control Unit Data Alert - Registrar
Production Automation and Quality Control Unit Data Alert - Registrar 2015-061 REVISED Casefinding List FY2016 Please see additions and revisions noted below in red text. ICD-10-CM Codes have been adopted
Serum Iron Studies
190.18 - Serum Iron Studies Serum iron studies are useful in the evaluation of disorders of iron metabolism, particularly iron deficiency and iron excess. Iron studies are best performed when the patient
MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site
POLICY: PG0364 ORIGINAL EFFECTIVE: 04/22/16 LAST REVIEW: 07/26/18 MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site GUIDELINES This policy does not certify benefits or authorization
ACR TXIT TM EXAM OUTLINE
ACR TXIT TM EXAM OUTLINE Major Domain Sub-Domain 1 Statistics 1.1 Study design 1.2 Definitions of statistical terms 1.3 General interpretation & analysis 1.4 Survival curves 1.5 Specificity/sensitivity
CLINICAL MEDICATION POLICY
CLINICAL MEDICATION POLICY Policy Name: Opdivo (nivolumab) injection Policy Number: Approved By: Medical Management, Clinical Pharmacy Products: Highmark Health Options Application: All participating hospitals
John R. Marsh Cancer Center
John R. Marsh Cancer Center Lung Program Overview: 2014-2015 Initiatives Lung CT Screening Dr. Gregory Zimmerman In cooperation with The Lung Cancer Steering Committee, Diagnostic Imaging Services at the
Contractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416)
Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor
NCD for Fecal Occult Blood Test
NCD for Fecal Occult Blood Test Applicable CPT Code(s): 82272 Blood, occult, by peroxidase activity (e.g., guaiac), qualitative, feces, 1-3 simultaneous determinations, performed for other than colorectal
SCCA REFERENCE MANUAL ICD-10
SCCA REFERENCE MANUAL ICD-10 NORTHWEST HOSPITAL 1 BREAST CANCER BREAST (INC. PAGET S DISEASE) 0 - Nipple and areola 1 - Central portion 2 - Upper-inner quadrant 3 - Lower-inner quadrant 4 - Upper-outer
Carcinoembryonic Antigen
Other Names/Abbreviations CEA 190.26 - Carcinoembryonic Antigen Carcinoembryonic antigen (CEA) is a protein polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring
California Cancer Registry Production Automation and Quality Control Unit Data Alert - Registrar
Production Automation and Quality Control Unit Data Alert - Registrar 2015-063 REVISED - Clarification Casefinding List for FY2016 Updated Please see additional codes inadvertently excluded from the previous
HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011
HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 SONGKLANAGARIND HOSPITAL FACULTY OF MEDICINE PRINCE OF SONGKLA UNIVERSITY HATYAI SONGKHLA THAILAND EDITOR PARADEE PRECHAWITTAYAKUL, B.Sc. June, 2013 Songklanagarind
Table of Contents. Last updated by CLO: 5/8/2013 1
Table of Contents Drug-induced liver injury algorithm - Cases... 2 Drug-induced liver injury algorithm - Controls... 3 1. Summary of drug-induced liver injury algorithm... 4 2. Terminology... 4 3. Threshold
American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013
American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 All ages Younger than 45 45 and Older Younger than 65 65 and Older All sites, men 306,920 9,370 297,550 95,980 210,940 All sites,
Icd 10 code metastatic adenocarcinoma endometrial
Icd 10 code metastatic adenocarcinoma endometrial 1-10-2017 Free, official coding info for 2018 ICD-10-CM D07.0 - includes detailed rules, notes, synonyms, ICD-9-CM conversion,. 2018 ICD-10-CM Diagnosis
Peripheral Nerve Blocks
Last Review Date: April 21, 2017 Number: MG.MM.ME.64v2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
Contractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information
Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor
Clinical Coding for CRS Standards
Clinical Coding for CRS Standards The following appendices set out the amended PRIMARY DIAGNOSIS coding structure to be used for the monitoring of cancer waiting times following the implementation of 4th
Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute
2008 ANNUAL REPORT Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute Cancer Registry Report The Cancer Data Management System/ Cancer Registry collects data on all types of cancer
2016 Cancer Registry Annual Report
2016 Cancer Registry Annual Report Cancer Committee Chairman s Report The Cancer Committee at Cancer Treatment Centers of America (CTCA) at Eastern Regional Medical Center (Eastern), established in 2006,
Contractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information
Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor
HCPCS Codes (Alphanumeric, CPT AMA) ICD-9-CM Codes Covered by Medicare Program
HCPCS s (Alphanumeric, CPT AMA) 82272 Blood, occult, by peroxidase activity (e.g., guaiac), qualitative, feces, 1-3 simultaneous determinations, performed for other than colorectal neoplasm screening ICD-9-CM
Florida Cancer Data System STAT File Documentation Version 2019
Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status
A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files
A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files By Dr. Martin A. Whiteside Director, Office of Cancer
A B ING TON HO SPITAL J E F F E R SO N H E ALTH 2018 ANNUAL REPORT CANCER
A B ING TON HO SPITAL J E F F E R SO N H E ALTH 2018 ANNUAL REPORT CANCER TABLE OF CONTENTS The New Asplundh Cancer Pavilion...2 Program Achievements...3 Breast Cancer: 2016 Analysis... 4 Summary of All
Gamma Glutamyl Transferase
Other Names/Abbreviations GGT 190.32 - Gamma Glutamyl Transferase Gamma glutamyl transferase (GGT) is an intracellular enzyme that appears in blood following leakage from cells. Renal tubules, liver, and
RADIATION THERAPY SERVICES CSHCN SERVICES PROGRAM PROVIDER MANUAL
RADIATION THERAPY SERVICES CSHCN SERVICES PROGRAM PROVIDER MANUAL APRIL 2018 CSHCN PROVIDER PROCEDURES MANUAL APRIL 2018 RADIATION THERAPY SERVICES Table of Contents 34.1 Enrollment......................................................................
Outcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.
Pembrolizumab (Keytruda )
Last Review Date: March 14, 2017 Number: MG.MM.PH.10f Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
Radiation Therapy Services
Radiation Therapy Services Chapter.1 Enrollment..................................................................... -2.2 Benefits, Limitations, and Authorization Requirements...........................
Cancer survival in Shanghai, China,
Cancer survival in Shanghai, China, 1992 1995 Xiang YB, Jin F and Gao YT Abstract The Shanghai cancer registry, established in 1963, is the oldest one in mainland China; cancer registration is entirely
REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2017 and after
REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2017 and after The following lists are intended to assist you, as the reporter, in identifying the reportable neoplasms for your facility. Any reportable
ICD-10 and Radiation Oncology
ICD-10 and Radiation Oncology Steven M. Verno, CEMCS ICD-10 and Radiation Oncology Steven M. Verno, CEMCS September 23, 2008 Note: ICD-9-CM and ICD-10 are owned and copyrighted by the World Health Organization.
Avastin Sample Coding
First- and Second-line Metastatic Colorectal Cancer C18.0 Malignant neoplasm of the cecum C18.1 Malignant neoplasm of appendix C18.2-C18.9 C19 C20 C21.8 Malignant neoplasm of the colon, various sites Malignant
Genetic Testing for Cancer Susceptibility
Last Review Date: March 10, 2017 Number: MG.MM.AD.17v3 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013
LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013 Landmark Medical Center offers a comprehensive cancer care services to our patients. LMC Cancer program is committed to ensure that patients receive
Oncology Centre Research Unit TUMOR REGISTRY
1 Oncology Centre Research Unit TUMOR REGISTRY ANNUAL REPORT 2013 1 Annual Report Prepared by the Staff of the Tumor Registry Research Unit, Oncology Centre King Faisal Specialist Hospital and Research
NEW/REVISED MATERIAL: Presented in italicized text EFFECTIVE DATE: January 1, 2008 GUIDELINES FOR REPORTING ADMINISTRATION OF EPOGEN MEDICARE
DISCLAIMER: Please be advised that while every effort has been made to ensure the accuracy of the information provided according to the most current LCD pertaining to the subject, periodic change to rules
2012 Cancer Report 2011 Registry Data
2012 Cancer Report 2011 Registry Data Contents Goals and Objectives 1 2012 Cancer Committee Members 2 Total Cancer Cases 1981-2011 3 Cancer Registry Frequency Report 1981-2011 4-5 Cancer Registry Frequency
CLINICAL MEDICATION POLICY
Policy Name: Policy Number: Approved By: CLINICAL MEDICATION POLICY Keytruda (pembrolizumab) MP-014-MD-DE Medical Management; Clinical Pharmacy Provider Notice Date: 01/15/2018; 08/01/2017; 06/01/2016
Cancer A Superficial Introduction
Cancer A Superficial Introduction Gabor Fichtinger, Queen s University Cancer some definitions Medical term: malignant neoplasm Class of diseases in which a group of cells display: uncontrolled growth
Introduction to ICD-O-3 coding rules
Introduction to ICD-O-3 coding rules Weena Laddachayaporn, MD National Cancer Institute, Bangkok, Thailand ICD-O-3 The International Classification of Diseases for Oncology Is a coding system for primary
Contractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography (CT), Thorax (L33459) Document Information
Local Coverage Determination (LCD): Computerized Axial Tomography (CT), Thorax (L33459) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information
All Discovered Death Outcome Detail (Form 124/120)
This file includes all reported deaths regardless of consent. ID WHI Common ID Col#1 DEATHALL All Discovered Death Col#2 Any report of death, regardless of consent status. 0 No 106,931 66.1 1 Yes 54,877
National Cancer Patient Experience Survey 2016 Technical Documentation July 2017
National Cancer Patient Experience Survey 2016 Technical Documentation July 2017 1 Contents 1. Introduction 2. Scoring 3. Significance Tests (for national data) 4. Case-mix Adjustment (for local data)
Gary M. Levin, BA, CTR FCDS Annual Conference 7/26/2017
Gary M. Levin, BA, CTR FCDS Annual Conference 7/26/2017 Presentation Overview Background Methods Results Conclusions 2 1 Background Increase physician reporting Capture missing first course treatment Capture
Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).
Appendix Definitions of Index Admission and Readmission Definitions of index admission and readmission follow CMS hospital-wide all-cause unplanned readmission (HWR) measure as far as data are available.
SKCC Protocol Review Committee New Study Application
Instructions: Submit the following documents to prc@jefferson.edu - Completed New Study Application (aka MCSF) - Protocol - Protocol Facilitation Committee Approval (if applicable) - MDG Priority Score
Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018)
Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018) Please refer to your standard setter(s) for specific reporting requirements before using
Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths
RSNA, 2016 10.1148/radiol.2016152472 Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths Observed/Expected No. of Deaths Observed/Expected
CLINICAL MEDICAL POLICY
CLINICAL MEDICAL POLICY Policy Name: Avastin (bevacizumab) Policy Number: MP-030-MD-DE Responsible Department(s): Medical Management; Clinical Pharmacy Provider Notice Date: 10/01/2017 Original Effective
Breast Carcinoma The Hard Way
Women s Health Breast Carcinoma The Hard Way C50 - Malignant neoplasm of breast C50.0 Malignant neoplasm of nipple and areola C50.01 - Malignant neoplasm of nipple and areola, female C50.011 - Malignant
The European Commission s science and knowledge service. Joint Research Centre
The European Commission s science and knowledge service Joint Research Centre Coding Primary Site and Tumour Morphology JRC-ENCR training course Copenhagen, 25 September 2018 Nadya Dimitrova Outline What
CLINICAL MEDICAL POLICY
Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICAL POLICY Opdivo (nivolumab) MP-004-MC-PA Medical Management; Clinical Pharmacy Provider Notice Date: 09/01/2018; 06/15/2018; 04/01/2017
Chapter II: Overview
: Overview Chapter II: Overview This chapter provides an overview of the status of cancer in Minnesota, using cases reported to the Minnesota Cancer Surveillance System (MCSS) and deaths reported to the
Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15
1 1500 MALIGNANT NEOPLASM OF CERVICAL ESOPHAGUS 1 1501 MALIGNANT NEOPLASM OF THORACIC ESOPHAGUS 1 1502 MALIGNANT NEOPLASM OF ABDOMINAL ESOPHAGUS 1 1503 MALIGNANT NEOPLASM OF UPPER THIRD OF ESOPHAGUS 1
FY 2016 MCRCEDP Approved ICD-10 Code List
Approved List C18.0 Malignant neoplasm of cecum C18.1 Malignant neoplasm of appendix C18.2 Malignant neoplasm of ascending colon C18.3 Malignant neoplasm of hepatic flexure C18.4 Malignant neoplasm of
Coding Companion for General Surgery/ Gastroenterology. A comprehensive illustrated guide to coding and reimbursement
Coding Companion for General Surgery/ Gastroenterology A comprehensive illustrated guide to coding and reimbursement 2011 Contents Getting Started with Coding Companion...i Skin...1 Pilonidal Cyst...23
Annual Report CANCER REGISTRY. at Eastern Regional Medical Center. Cancer Treatment Centers of America. Philadelphia, Pennsylvania.
CANCER REGISTRY Annual Report 207 Cancer Treatment Centers of America at Eastern Regional Medical Center Philadelphia, Pennsylvania Chicago, Illinois Atlanta, Georgia Tulsa, Oklahoma Phoenix, Arizona 206
CHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster
CHAPTER 10 CANCER REPORT Jeremy Chapman and Angela Webster CANCER REPORT ANZDATA Registry 2004 Report This report summarises the cancer (excluding nonmelanocytic skin cancer) experience of patients treated
Advanced colon cancer icd 10
Advanced colon cancer icd 10 rules, notes, synonyms, ICD -9-CM conversion, index and annotation crosswalks, DRG grouping and. Survive bowel cancer for 10 or more years, 2010-11, England and Wales. Icd
Chapter 2 Neoplasms C00-D49 November 11, Chapter 2: Neoplasms Category: C00-D49 Official Coding Guidelines: Section 1.C.2, p.
Chapter 2: Neoplasms Category: C00-D49 Official Coding Guidelines: Section 1.C.2, p. 22 1 C00 C75 Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, hematopoietic
Comprehensive cancer cover
Retirement Investments Insurance Health Comprehensive cancer cover Life Insurance+ with critical illness and Critical Illness+ Cancer is one of the biggest fears for the British public This is why our
Republican Research and Practical Center for Radiation Medicine and Human Ecology. Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus
Republican Research and Practical Center for Radiation Medicine and Human Ecology Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus The contaminated area in the Republic of Belarus consisted
Cancer in Utah: An Overview of Cancer Incidence and Mortality from
Cancer in Utah: An Overview of Cancer Incidence and Mortality from 1973-2010 A publication of the Utah Cancer Registry January 2014 Prepared by: C. Janna Harrell, MS Senior Research Analyst Kimberly A.
Cancer in Colorado Incidence, Mortality, and Survival
Cancer in Colorado 1998-2003 Incidence, Mortality, and Survival Jack L. Finch, M.S. Statistical Analyst III Kieu O. Vu, M.S.P.H. Statistical Analyst II 2007 Colorado Central Cancer Registry Randi K. Rycroft,
2016 Public Outcomes Report
2016 Public Outcomes Report The Lefcourt Family Cancer Treatment and Wellness Center at Englewood Hospital and Medical Center is a Compre hensive Community Cancer Program, designated by the Commission
Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute
Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute Paul R. Yarnold, Ph.D. and Robert C. Soltysik, M.S. Optimal Data Analysis, LLC Imagine a random sample
Cancer Treatment Centers of America ATLANTA CANCER REGISTRY. Annual Report
Cancer Treatment Centers of America ATLANTA CANCER REGISTRY Annual Report CANCER COMMITTEE Chairman s Report On behalf of the Cancer Committee a multidisciplinary team of boardcertified physicians and
Macmillan Publications
S1 S2 S3 S3 S3 S4 S5 S6 S7 S8 S8 S9 S10 S11 S11 S12 S13 S14 S15 S17 S18 S19 Bladder Cancer: Non-Invasive, Invasive and Advanced Bone Cancer: Primary, Secondary Colon Cancer, Anal Cancer, Rectal Cancer